Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/230.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Virus or component thereof > Herpetoviridae (e.g., herpesvirus, marek`s disease virus, laryngotracheitis virus, infectious bovine rhinotracheitis virus (ibr), infectious pustular vulvovaginitis virus, bovine herpes virus type 1, aujeszky`s disease virus, feline rhinotracheitis virus, feline herpes virus, etc.) > Cytomegalovirus, varicella or herpes zoster virus, or epstein-barr virus
Description: Subject matter wherein the virus is a cytomegalovirus, a varicella or herpes zoster virus, or an Epstein-Barr virus.










Patents under this class:
1 2 3 4

Patent Number Title Of Patent Date Issued
8673317 Codon-optimized polynucleotide-based vaccines against human Cytomegalovirus infection Mar. 18, 2014
8603480 Human cytomegalovirus neutralizing antibodies and use thereof Dec. 10, 2013
8586034 Cytomegalovirus disintegrin-like peptides Nov. 19, 2013
8580276 Genetically stable recombinant modified vaccinia ankara (rMVA) vaccines and methods of preparation thereof Nov. 12, 2013
8551527 Process for stabilizing an adjuvant containing vaccine composition Oct. 8, 2013
8545848 Human cytomegalovirus neutralising antibodies and use thereof Oct. 1, 2013
8535930 Expression of proteins in plants Sep. 17, 2013
8501194 Vaccine for viruses that cause persistent or latent infections Aug. 6, 2013
8481051 Cytotoxic T-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof Jul. 9, 2013
8435524 Human cytomegalovirus neutralizing antibodies and use thereof May. 7, 2013
8425898 Compositions, methods, and kits for eliciting an immune response Apr. 23, 2013
8309089 Human cytomegalovirus neutralising antibodies and use thereof Nov. 13, 2012
8298538 Human cytomegalovirus neutralising antibodies and use thereof Oct. 30, 2012
8298539 Human cytomegalovirus neutralizing antibodies and use thereof Oct. 30, 2012
8287870 Human cytomegalovirus neutralizing antibodies and use thereof Oct. 16, 2012
8241639 Extracellular domains of Epstein Barr Virus (EBV) tumor-associated latent membrane proteins Aug. 14, 2012
8173362 Cytomegalovirus surface protein complex for use in vaccines and as a drug target May. 8, 2012
8124093 Human cytomegalovirus neutralizing antibodies and use thereof Feb. 28, 2012
8029796 Therapeutic anti-cytomegalovirus compounds Oct. 4, 2011
7976845 Human cytomegalovirus immunotherapy Jul. 12, 2011
7955599 Human cytomegalovirus neutralizing antibodies and use thereof Jun. 7, 2011
7951770 Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated fusion and entry process May. 31, 2011
7947274 Human cytomegalovirus neutralising antibodies and use thereof May. 24, 2011
7939084 Vaccine against varicella zoster virus May. 10, 2011
7910092 Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases Mar. 22, 2011
7811581 Epstein Barr Virus (EBV) tumor-associated latent membrane extracellular domain peptides Oct. 12, 2010
7763261 Anti-human cytomegalovirus antibodies Jul. 27, 2010
7704510 Cytomegalovirus surface protein complex for use in vaccines and as a drug target Apr. 27, 2010
7611718 Attenuation of cytomegalovirus virulence Nov. 3, 2009
7550149 Attenuation of cytomegalovirus virulence Jun. 23, 2009
7537770 Attenuation of cytomegalovirus virulence May. 26, 2009
7524503 Human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor Apr. 28, 2009
7501129 Vectors comprising guinea pig CMV regulatory elements Mar. 10, 2009
7465580 Non-cytotoxic oriP replicon Dec. 16, 2008
7427469 Method of treating cytomegalovirus with DC-SIGN blockers Sep. 23, 2008
7422751 Epstein-barr-virus-specific immunization Sep. 9, 2008
7419674 Alpha virus-based cytomegalovirus vaccines Sep. 2, 2008
7399825 Synthetic peptide, inhibitor to DNA viruses Jul. 15, 2008
7387782 Protein kinase deficient, immunologically active CMVpp65 mutants Jun. 17, 2008
7326535 Immunoreactive peptides from Epstein-Barr virus Feb. 5, 2008
7271148 Inhibition of cellular proteases Sep. 18, 2007
7208165 Human cytomegalovirus DNA sequences Apr. 24, 2007
7204990 Attenuation of cytomegalovirus virulence Apr. 17, 2007
7202331 Therapeutic anti-cytomegalovirus compounds Apr. 10, 2007
7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders Mar. 20, 2007
7147861 Human cytomegalovirus glycoprotein O as a new drug target and subunit vaccine candidate Dec. 12, 2006
7135186 Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use Nov. 14, 2006
7118755 Herpes viruses for immune modulation Oct. 10, 2006
7112331 Vaccines against varicella zoster virus gene 63 product Sep. 26, 2006
7063851 Herpes viruses for immune modulation Jun. 20, 2006

1 2 3 4










 
 
  Recently Added Patents
Latch-up free ESD protection
Information-provision control method, information reproduction system, information-provision apparatus, information reproduction apparatus and information-presentation control program
Optical coherence tomography with multiple sample arms
Administrable compositions
Address generation unit for accessing a multi-dimensional data structure in a desired pattern
Tone enhancement bracket
Label printer
  Randomly Featured Patents
Method and device for sensing bioelectrical signals
Cart protein
Binding device for bundling openings of bags or the like
Portable cooled merchandizing unit
Semiconductor memory device and method for executing shift redundancy operation
Dual work function CMOS device
Exhaust heat recovery apparatus
Printer
Toner, production method thereof, and image forming apparatus using same
Image capture method, system and apparatus